Skip to content
Clinical ResearchResearch compoundLimited evidence

Coluracetam

Experimental nootropic (racetam-type compound): increased choline uptake by nerve cells in animal studies, not proven in humans.

NootropicRacetamCholinergicRacetamCholinergicAcetylcholine

Pharmacology

ClassRacetam · Cholinergic
Primary targetHigh-affinity choline uptake transporter (CHT1/HACU)
Targets3 receptor targets
EvidenceLimited evidence
Affected systemsAcetylcholine

Contents

Related comparisons

Pramiracetam vs Coluracetam

DETAILED OVERVIEW

What is Coluracetam?

Coluracetam (BCI-540, formerly MKC-231) is an experimental compound of the racetam type, originally developed to improve thinking. It is not an approved medicine anywhere and is sold as a research chemical.

It speeds up the uptake of choline, a building block, into nerve cells, so more acetylcholine (one of the brain's messengers) is made and released. In animal studies its effect lasted for up to 8 days after administration. So far it has been studied mainly in animals and is not proven in humans: an early study in depression and anxiety also did not confirm that it works. Users report more vivid colors and a better mood, but no study has confirmed this. Headache, nausea and anxiety can occur. There is no safety data for pregnancy and breastfeeding, nor for long-term use.

Mechanism

Selectively boosts choline uptake into nerve cells

Half-life

~3 h

Legal status

Investigational, no approval

Receptor profile

  • Choline transporter CHT1 (HACU)Strong
  • Cholinergic signalingModerate
  • AMPA receptorsWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Headache, often from increased acetylcholine demand (can be mitigated by choline intake)
  • Excess cholinergic effects: nausea, gastrointestinal discomfort
  • Anxiety, irritability, overstimulation (cholinergic overdrive)
  • Crash between doses due to short duration of action (~3 hour half-life)
  • Fatigue, brain fog when choline stores become depleted
  • Unpleasant, lingering taste with sublingual use

Contraindications · 5

  • Pregnancy and breastfeeding: no safety data, should be avoided
  • Combining with other cholinergics (cholinesterase inhibitors, high-dose choline) may cause additive cholinergic excess
  • Caution in anxiety disorders: cholinergic overstimulation may worsen anxiety
  • Unapproved experimental compound with no long-term human safety data
  • Only under medical supervision when treating depression (Phase 2A trial did not confirm efficacy)

Related Nootropics

Same therapeutic category

FAQ

FAQ

Coluracetam is a racetam-type compound originally developed as a cognitive enhancer, notable because in animal studies a single dose could keep working for days. Users often report visual effects (brighter colors, more contrast) and mood lift, but the source material doesn't spell out solid confirmed benefits, so it's more of an anecdotal, under-researched profile.

Telegram

Have a question about Coluracetam?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC19H23N3O3
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.